PUBLIC HEALTH

The benefits and risks of mass antibiotic use for reducing child mortality

Article metrics

Mass administration of azithromycin to young children at risk of dying could reduce harmful intestinal pathogenic bacteria and impact survival, but also increase antibiotic resistance.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1

References

  1. 1.

    Doan. T. et al. Nat. Med. https://doi.org/10.1038/s41591-019-0533-0 (2019).

  2. 2.

    Porco, T. C. et al. J. Am. Med. Assoc. 302, 962–968 (2009).

  3. 3.

    Keenan, J. D. et al. N. Engl. J. Med. 378, 1583–1592 (2018).

  4. 4.

    Oldenburg, C. E. et al. Am. J. Trop. Med. Hyg. 100, 691–695 (2019).

  5. 5.

    Arzika, A. M. et al. PLoS Med. 16, e1002835 (2019).

  6. 6.

    Chandramohan, D. et al. N. Engl. J. Med. 380, 2197–2206 (2019).

  7. 7.

    Doan, T. et al. Open Forum Infect. Dis. 5, ofy182, https://doi.org/10.1093/ofid/ofy182 (2018).

  8. 8.

    Liu, J. et al. Lancet 388, 1291–1301 (2016).

  9. 9.

    Rogawski, E.T. et al. Lancet Glob. Health 6, e1319–e1328.

  10. 10.

    Whitty, C. J., Glasgow, K. W., Sadiq, S. T., Mabey, D. C. & Bailey, R. Pediatr. Infect. Dis. J. 18, 955–958 (1999).

  11. 11.

    Keenan, J. D. et al. PLoS Negl. Trop. Dis. 13, e0007442 (2019).

  12. 12.

    Doan, T. et al. N. Engl. J. Med. 380, 2271–2273 (2019).

Download references

Author information

Correspondence to Zulfiqar A. Bhutta.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bhutta, Z.A. The benefits and risks of mass antibiotic use for reducing child mortality. Nat Med 25, 1332–1334 (2019) doi:10.1038/s41591-019-0576-2

Download citation